Crosscope. a provider of AI-enabled digital pathology software, and Mindpeak, known for its AI tools for clinical diagnosis, have announced a partnership to integrate Mindpeak’s image analysis tools into the Crosscope digital pathology platform.
This partnership will enable Crosscope to expand its portfolio of AI applications and deliver end-to-end digital pathology solutions.
Mindpeak has developed tools that analyse immunohistochemically stained tissue samples by immediately detecting, classifying and quantifying breast cancer cells. Crosscope Dx, a workflow integrated vendor-agnostic digital pathology platform will use Mindpeak’s CE-marked BreastIHC and follow-on products each as a supplementary module within the workflow software that will enable pathologists with diagnostics support in the evaluation of histopathology images or image sections. With this strategic partnership, Crosscope will be the authorised partner of Mindpeak for India and emerging markets.
This partnership enables the integration of image analysis solutions for ER, PR and Ki-67 IHC staining into Crosscope that will support pathologists to improve the efficiency of their pathology laboratories and provide a timely diagnosis for their patients, ultimately impacting their treatment and outcomes.
Crosscope, as a leading AI software provider in digital pathology, wants to ensure that Mindpeak’s cutting-edge technology is available for the pathology community to enable digital transformation in the pathology laboratories in India and emerging markets, the USA and Europe.
